EUVIMEDEUVIMED entdecken
Crossref

Patient-Reported Outcomes Reveal Distinct Sinonasal Phenotype in Vitiligo-Associated Chronic Rhinosinusitis

Aaron D Smith, Catherine E. Lyons, Fady E Attia, Micaela Anne Shulman, Larry Borish

Libra · 10.09.2026

DOI: 10.18130/c178-r228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Libra, erschienen am 10.09.2026. Verfasst von Aaron D Smith und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vitiligo is a chronic, T1-skewed autoimmune depigmentation disorder associated with substantial psychosocial burden and a range of immune-mediated comorbidities. Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory condition whose clinical expression is shaped by underlying immune endotype and systemic comorbidity. While CRS prevalence is elevated in patients with vitiligo, the impact of vitiligo on CRS phenotype and symptom burden has not been characterized. This study evaluated whether CRS in patients with vitiligo exhibits a distinct clinical profile compared with CRS alone.

Methods

In this retrospective study, 13 patients with comorbid vitiligo and CRS were compared to 137 patients with CRS without nasal polyps and 49 with CRS with nasal polyps, both without autoimmune comorbidity. CRS severity was assessed using the Sino-Nasal Outcome Test (SNOT-22), Lund-Mackay Score (LMS), Lund-Kennedy Score (LKS), serum IgE, absolute eosinophil count, and nasal polyp presence.

Results

Demographics were similar across groups. Objective disease burden was greatest in CRS with nasal polyps. Despite carrying intermediate LMS and LKS scores, vitiligo-associated CRS demonstrated the highest total SNOT-22 scores (p = 0.04), with significant elevations in need to blow the nose, sneezing, ear fullness, ear pain, dizziness, facial pain, fatigue, and sleep quality.

Conclusions

Vitiligo confers a distinct CRS phenotype characterized by disproportionately elevated subjective symptom burden relative to objective disease severity. This discordance may reflect systemic neuroimmune amplification driven by vitiligo's T1 dominant cytokine environment, underscoring the importance of patient reported outcomes and multidisciplinary management in this population.

Schlagwörter

vitiligochronic rhinosinusitisnasal polypspatient-reported outcomessymptom burdenSNOT-22Lund-Mackay scoreLund-Kennedy scoreserum IgEeosinophil count

Zitieren

APA

Smith, A. D., Lyons, C. E., Attia, F. E., Shulman, M. A., & Borish, L. (2026). Patient-Reported Outcomes Reveal Distinct Sinonasal Phenotype in Vitiligo-Associated Chronic Rhinosinusitis. Libra. https://doi.org/10.18130/c178-r228

Vancouver

Smith AD, Lyons CE, Attia FE, Shulman MA, Borish L. Patient-Reported Outcomes Reveal Distinct Sinonasal Phenotype in Vitiligo-Associated Chronic Rhinosinusitis. Libra. 2026. doi:10.18130/c178-r228

BibTeX
@article{Smith2026,
  author = {Smith, Aaron D and Lyons, Catherine E. and Attia, Fady E and Shulman, Micaela Anne and Borish, Larry},
  title = {Patient-Reported Outcomes Reveal Distinct Sinonasal Phenotype in Vitiligo-Associated Chronic Rhinosinusitis},
  journal = {Libra},
  year = {2026},
  doi = {10.18130/c178-r228}
}
Kostenlos starten →